InfiniWell BPC-Lx Pro Technology: lipid-based oral fine mist Why it is plausible Buccal delivery can avoid part of the GI pathway
Researchers consistently identify properly designed human clinical trials as the critical next step for establishing clinical relevance
During the opening lecture at the International Conference on Advanced Technologies & Treatments for Diabetes, Melanie Davies, CBE, MB, ChB, MD, FRCP, FRCGP, professor of diabetes medicine at the University of Leicester and an honorary consultant diabetologist at the University Hospitals of Leicester NHS Trust, reviewed how GLP-1 receptor agonists such as semaglutide (Ozempic/Wegovy, Novo Nordisk) have changed the way providers approach the treatment of type 2 diabetes and obesity and discussed some of the medications that combine GLP-1 with other molecules
Healing is more than just making tissue grow, its also doing it in the right place, the right amount, at the right time
So happy to be back with exciting new products to share
Z.AnsariniyaH.SeifatiS
